These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18793573)

  • 1. Comment on Ibernon et al. Clin Nephrol 2008; 69: 395-401.
    Stassen PM; Tervaert JW; Stegeman CA
    Clin Nephrol; 2008 Sep; 70(3):270. PubMed ID: 18793573
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity.
    Ibernon M; Poveda R; Vidaller A; Bestard O; Grinyó JM
    Clin Nephrol; 2008 Jun; 69(6):395-401. PubMed ID: 18538114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis.
    Jones R; Shah S; MacMahon EE; Goldsmith DJ
    Nephrol Dial Transplant; 2003 Sep; 18(9):1920-2. PubMed ID: 12937244
    [No Abstract]   [Full Text] [Related]  

  • 4. [New treatments for systemic diseases].
    Bader-Meunier B; Willems M
    Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Tervaert JW; Stegeman CA; Kallenberg CG
    Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):211-7. PubMed ID: 11224696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil in systemic vasculitis.
    D'Cruz DP
    Lupus; 2005; 14 Suppl 1():s55-7. PubMed ID: 15803934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in ANCA-associated vasculitis.
    van der Woude FJ; Schmitt WH; Birck R; Nowack R; Göbel U; Drexler JM; Hotta O
    Transplant Proc; 2001 May; 33(3):2225-6. PubMed ID: 11377509
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute hepatitis following mycophenolate mofetil administration for ANCA-positive vasculitis.
    Dourakis SP; Boki K; Soultati A; Cherouvim E; Delladetsima I
    Scand J Rheumatol; 2007; 36(3):237-9. PubMed ID: 17657683
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis.
    Stegeman CA
    Nephrol Dial Transplant; 2002 Dec; 17(12):2077-80. PubMed ID: 12454214
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vasculitis attacking the kidneys].
    Grönhagen-Riska C; Teppo AM
    Duodecim; 1995; 111(15):1442-51. PubMed ID: 9244700
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
    Zhang X; Dong Y; Zeng X; Li Y; Tang F
    Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mizoribine induces remission of relapsed ANCA-associated renal vasculitis.
    Nishioka Y; Horita Y; Tadokoro M; Taura K; Suyama N; Miyazaki M; Harada T; Kohno S
    Nephrol Dial Transplant; 2006 Apr; 21(4):1087-8. PubMed ID: 16326748
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement.
    Iatrou C; Zerbala S; Revela I; Spanou E; Marinaki S; Nakopoulou L; Boletis J
    Clin Nephrol; 2009 Jul; 72(1):31-7. PubMed ID: 19640385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential immunosuppressive therapeutics to target small vessel vasculitis of the kidney.
    Williams JM
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1142-8. PubMed ID: 16312136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of mycophenolic acid in non-transplant renal diseases.
    Stassen PM; Kallenberg CG; Stegeman CA
    Nephrol Dial Transplant; 2007 Apr; 22(4):1013-9. PubMed ID: 17307748
    [No Abstract]   [Full Text] [Related]  

  • 17. Subarachnoid hemorrhages in vasculitis.
    Thompson B; Burns A
    Am J Kidney Dis; 2003 Sep; 42(3):582-5. PubMed ID: 12955688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPO antibody-positive vasculitis in a patient with psoriatic arthritis and gold-induced membranous glomerulonephritis.
    Quarenghi MI; Del Vecchio L; Casartelli D; Manunta P; Rossi R
    Nephrol Dial Transplant; 1998 Aug; 13(8):2104-6. PubMed ID: 9719174
    [No Abstract]   [Full Text] [Related]  

  • 19. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.